F
Filip K. Knop
Researcher at University of Copenhagen
Publications - 523
Citations - 17834
Filip K. Knop is an academic researcher from University of Copenhagen. The author has contributed to research in topics: Type 2 diabetes & Diabetes mellitus. The author has an hindex of 61, co-authored 437 publications receiving 13614 citations. Previous affiliations of Filip K. Knop include Copenhagen University Hospital & Victor Chang Cardiac Research Institute.
Papers
More filters
Journal ArticleDOI
Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring.
Caroline T B Juel,Thomas F. Dejgaard,Thomas F. Dejgaard,Carsten P. Hansen,Jan H Storkholm,Tina Vilsbøll,Tina Vilsbøll,Asger Lund,Asger Lund,Filip K. Knop +9 more
TL;DR: CGM-assessed glycemic variability showed higher CONGA60 min and time spent above range in totally pancreatectomized PX patients compared with HbA1c-matched T1D patients.
Journal ArticleDOI
Myocardial Impairment and Acute Respiratory Distress Syndrome in Hospitalized Patients With COVID-19: The ECHOVID-19 Study.
K Skaarup,Mats Christian Højbjerg Lassen,Jannie Nørgaard Lind,Alia Saed Alhakak,Morten Sengeløv,Anne Bjerg Nielsen,Caroline Espersen,Raphael Hauser,Liv Borum Schöps,Eva Holt,Niklas Dyrby Johansen,D Modin,Shreeya Sharma,Claus Graff,Henning Bundgaard,Christian Hassager,Reza Jabbari,Anne-Mette Lebech,Ole Kirk,Uffe Bodtger,Matias Greve Lindholm,Gowsini Joseph,Lothar Wiese,Frank Vinholt Schiødt,Ole Peter Kristiansen,Emil Schwarz Walsted,Olav Wendelboe Nielsen,Birgitte Lindegaard Madsen,Niels Tønder,Thomas Benfield,Klaus Nielsen Jeschke,Charlotte Suppli Ulrik,Filip K. Knop,Jannik Langtved Pallisgaard,Morten Lamberts,Pradeesh Sivapalan,Gunnar Gislason,Scott D. Solomon,Scott D. Solomon,Kasper Iversen,Jens-Ulrik Stæhr Jensen,Morten Schou,Tor Biering-Sørensen +42 more
TL;DR: In this paper, the authors found that acute respiratory distress syndrome (ARDS) is the primary complication observed in Coronavirus disease-2019 (COVID-19)related deaths.
Journal ArticleDOI
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.
Pradeesh Sivapalan,Charlotte Suppli Ulrik,Therese Sophie Lappere,Josefin Eklöf,Saher B. Shaker,Uffe Bodtger,Andrea Browatzki,Christian N Meyer,Ulla Møller Weinreich,Christian B. Laursen,Tor Biering-Sørensen,Filip K. Knop,Jens D Lundgren,Jens-Ulrik Stæhr Jensen +13 more
TL;DR: The ProPAC-COVID trial evaluates whether combination therapy with macrolide azithromycin and hydroxychloroquine via anti-inflammation/immune modulation, antiviral efficacy, and pre-emptive treatment of supra-infections can shorten hospitalization duration and reduce the risk of non-invasive ventilation.
Journal ArticleDOI
No Effect of Aprotinin (Trasylol™) on Degradation of Exogenous and Endogenous Glucagon in Human, Mouse and Rat Plasma
Monika Judyta Bak,Nicolai J. Wewer Albrechtsen,Bolette Hartmann,Jens Pedersen,Mikkel Christensen,Tina Vilsbøll,Filip K. Knop,Carolyn F. Deacon,Lars O. Dragsted,Jens J. Holst,Jens Juul Holst +10 more
TL;DR: Using RIAs directed against both the C-terminus and a mid-region of glucagon, this work challenged the classical view that aprotinin is necessary and found no support for use of aProtinin for prevention of glucagons degradation.
Journal ArticleDOI
Therapy for Obesity Based on Gastrointestinal Hormones
TL;DR: An overview of intestinal peptides with promising effects as potential new treatments for obesity is provided, and two different incretin therapies are widely used in the treatment of type 2 diabetes: the GLP-1 receptor agonists which cause significant and sustained weight loss in overweight patients, and dipeptidyl peptidase 4 (DPP-4) inhibitors being weight neutral.